Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
出版年份 2009 全文链接
标题
Cytokines and Cytokine Profiles in Human Autoimmune Diseases and Animal Models of Autoimmunity
作者
关键词
-
出版物
MEDIATORS OF INFLAMMATION
Volume 2009, Issue -, Pages 1-20
出版商
Hindawi Limited
发表日期
2009-10-26
DOI
10.1155/2009/979258
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies
- (2009) Elizabeth W. Karlson et al. ARTHRITIS AND RHEUMATISM
- Proteomic toolbox for autoimmunity research
- (2009) Tianfu Wu et al. AUTOIMMUNITY REVIEWS
- Psoriasis, syndrome métabolique et ses composants
- (2008) J.-P. Ortonne ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study
- (2008) Mark C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus
- (2008) Robert Biesen et al. ARTHRITIS AND RHEUMATISM
- At the horizon of innovative therapy in rheumatology: new biologic agents
- (2008) Axel Finckh et al. CURRENT OPINION IN RHEUMATOLOGY
- Cytokines as Therapeutic Targets: Advances and Limitations
- (2008) Clemens Scheinecker et al. IMMUNITY
- Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
- (2008) Marc Feldmann et al. IMMUNOLOGICAL REVIEWS
- Ustekinumab for chronic plaque psoriasis
- (2008) Brenda L Bartlett et al. LANCET
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- Gene expression analysis of interferon-β treatment in multiple sclerosis
- (2008) F Sellebjerg et al. Multiple Sclerosis Journal
- Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
- (2008) Ausra Milano et al. PLoS One
- Signalling, inflammation and arthritis: Crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity
- (2008) V. Paunovic et al. RHEUMATOLOGY
- Interleukin-7 in rheumatoid arthritis
- (2008) S. M. Churchman et al. RHEUMATOLOGY
- Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity
- (2008) H. P. Carroll et al. RHEUMATOLOGY
- Genetic epidemiology: the use of old and new tools for multiple sclerosis
- (2008) Sreeram V. Ramagopalan et al. TRENDS IN NEUROSCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started